ReviewHead and neck pathology2025
Metastatic SMARCA4-Deficient Undifferentiated Carcinoma of the Oral Cavity: A Case Report and Review of Literature.
Review in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Peri-Implant Gingival Undifferentiated SWI/SNF Complex-Deficient Tumor with Molecularly Confirmed Biallelic SMARCA4 Inactivation: Diagnostic Pitfalls and Genomic Characterization.Diagnostics (Basel, Switzerland) · 2026Article
- Epithelioid Sarcoma of the Oral Cavity: A Multi-institutional Clinicopathologic and Immunophenotypic Characterization of Five Cases and Comprehensive Literature Review.Head and neck pathology · 2026Review
- SMARCA4-deficient lung adenocarcinoma with oral cavity metastasis: a case report.BMC oral health · 2026Article
- Rare tongue base metastasis from SMARCA4-deficient undifferentiated non-small cell lung carcinoma: a case report.International journal of clinical and experimental pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSMARCA4-deficient high-grade malignancies are increasingly recognized across various anatomic sites, namely the genitourinary tract thorax, gastrointestinal tract, head and neck, and central nervous system. Within the head and neck region, the sinonasal tract is most commonly affected. These tumors are aggressive, often presenting with local or distant metastases at diagnosis, and median survival ranges from 4 to 7 months. We report a rare case of SMARCA4-deficient carcinoma presenting as a metastasis to the oral cavity, highlighting key histopathologic and clinical features. CASE REPORT: A 63-year-old woman presented with a 3.0 × 2.0 × 2.0 cm exophytic mass involving teeth #25-28 and a 4 cm poorly defined radiolucency in the mandible. Histologically, the tumor was composed of diffuse sheets of large polygonal epithelioid cells with indistinct borders, pale eosinophilic cytoplasm, vesicular pleomorphic nuclei, prominent nucleoli, and numerous atypical mitotic figures and apoptotic bodies. Immunohistochemistry showed focal positivity for pankeratin, CAM5.2, and claudin-4. The tumor was negative for S100, SOX10, and SMARCA4 (BRG1), confirming SMARCA4-deficiency. A CT scan revealed a 5.5 cm mandibular lesion and a 16 cm right upper lobe lung mass, with additional nodules in the contralateral lung, thyroid, kidney, and widespread lymphadenopathy. The findings were consistent with a primary thoracic SMARCA4-deficient undifferentiated tumor with diffuse metastases. The patient died within two months of initial diagnosis of the oral metastasis.
conclusionTo our knowledge, this is the first reported case of this unusual tumor metastasizing to the oral cavity. Given the aggressive nature and metastatic potential of these tumors, it is essential to evaluate for a distant primary malignancy when such a lesion is encountered in the head and neck.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.